JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances tantitumor function in a Fas/FasL signal-independent pathway

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances tantitumor function in a Fas/FasL signal-independent pathway

Yang Liu,1 Yue-ru Wang,2 Guang-hui Ding,1 Ting-song Yang,1 Le Yao,1 Jie Hua,1 Zhi-gang He,1 Ming-ping Qian1 1Department of Hepatobiliary Surgery, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China; 2Department of Infectio...

Full description

Bibliographic Details
Main Authors: Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:OncoTargets and Therapy
Subjects:
AFP-specific CD8+ T cells
JAK2 inhibitor
Fas/FasL signal
anti-tumor
apoptosis
Online Access:https://www.dovepress.com/jak2-inhibitor-combined-with-dc-activated-afp-specific-t-cells-enhance-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/jak2-inhibitor-combined-with-dc-activated-afp-specific-t-cells-enhance-peer-reviewed-article-OTT

Similar Items